Sign in
Taking people in United StatesNo phase

GPS tracking to help people without shelter take hepatitis C treatment

Tests whether GPS tracking helps unsheltered homeless people with hepatitis C keep taking medicine.

Key facts

Who runs it
University of Southern California
Where
Alhambra and Ventura, United StatesSee the 2 sites
Trial code
Registry title
Hepatitis C Tracker Study
Status
Recruiting
People taking part
124 people, planned
Started
8 Aug 2025
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • GPS tracker device
Record updated
29 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with hepatitis C who live unsheltered on the street and get care from street medicine teams. It tests whether a GPS tracker helps people keep taking their treatment.

Age
18 Years and older
Sex
All sexes
Disease stage
Hepatitis C infection that meets the AASLD criteria for simplified treatment. People with decompensated cirrhosis (severe liver scarring with failing liver) cannot join.
Earlier treatment
People who have already been treated for hepatitis C cannot join.
Biomarker or test result
People who test positive for HBsAg (a sign of hepatitis B) cannot join.

Main reasons for not taking part

  • Past hepatitis C treatment
  • Decompensated cirrhosis or positive HBsAg test
  • Being pregnant now
  • Known or suspected liver cancer (hepatocellular carcinoma)
  • Past liver transplant

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Diagnosed with Hepatitis C infection
  • Experiencing unsheltered homelessness at study initiation
  • Speaks English or Spanish
  • Receiving street medicine care
  • Meet the American Association for the Study of Liver Diseases (AASLD) criteria for simplified treatment of Hepatitis C

Who cannot take part

  • Prior engagement in HCV treatment
  • Prior liver transplantation
  • Decompensated cirrhosis; HBsAg positive
  • Current pregnancy; Known or suspended hepatocellular carcinoma

Where in United States

  • USC Street MedicineAlhambra, United StatesContact: Alexis Coulourides Kogan, PhDTaking people
  • Ventura County Medical CenterVentura, United StatesContact: Matthew Lamon, DOTaking people

About the trial

What the trial wants to find out

The goal of this study is to determine if GPS tracking can enhance adherence to hepatitis C treatment among patients diagnosed with hepatitis C infection who are also experiencing unsheltered homelessness and receiving street medicine. Research will compare medication adherence among participants randomly assigned to receive standard medical care for Hepatitis C versus the standard medical care for Hepatitis C along with GPS tracking assistance.

The 2 groups in the trial

  • Standard HCV treatmentNo study treatment, for comparison

    Participants randomized to this study arm will receive the standard medical care for Hepatitis C.

  • Standard HCV treatment + GPS tracker deviceExisting treatment, for comparison

    Participants randomized to this study arm will receive the standard medical care for Hepatitis C and a GPS tracker device.

    Treatment: GPS tracker device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Effects of GPS Tracking on Patient Adherence to Hepatitis C Treatment Among People Experiencing Unsheltered Homelessness
Plain-language title
GPS tracking to help people without shelter take hepatitis C treatmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
29 August 2025